Novel Therapeutic Targets for Diabetic Nephropathy

E-ISSN： 2212-3873|7|2|83-92

ISSN： 1871-5303

Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.7, Iss.2, 2007-06, pp. : 83-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine Receptors: New Therapeutic Targets for Inflammation in Diabetic Nephropathy

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 3, 2013-06 ,pp. : 153-161

Bentham Science Publishers

Access to resources Recommend Favorite

Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy - are these Receptors Valid Therapeutic Targets

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 42-50

Bentham Science Publishers

Access to resources Recommend Favorite

M1/M2 Macrophages in Diabetic Nephropathy: Nrf2/HO-1 as Therapeutic Targets

Current Pharmaceutical Design, Vol. 24, Iss. 20, 2018-06 ,pp. : 2241-2249

Bentham Science Publishers

Access to resources Recommend Favorite

Drosophila Renal Organ as a Model for Identification of Targets and Screening of Potential Therapeutic Agents for Diabetic Nephropathy

Current Drug Targets, Vol. 19, Iss. 16, 2018-12 ,pp. : 1980-1990

Bentham Science Publishers

Access to resources Recommend Favorite

Pimagedine: a novel therapy for diabetic nephropathy

By Bolton W Kline Abdel-Rahman Emaad

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 4, 2002-04 ,pp. : 565-574

Informa Healthcare

Access to resources Recommend Favorite